CERENO SCIENTIFIC AB B (4A1) — Cash Flow-to-Debt Ratio
CERENO SCIENTIFIC AB B (4A1) has a Cash Flow-to-Debt Ratio of -0.25x as of December 2025, meaning its operating cash flow of €-38.03 Million could theoretically repay 0% of its total liabilities (€150.20 Million) in one year. See 4A1 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CERENO SCIENTIFIC AB B Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for CERENO SCIENTIFIC AB B across 5 annual periods. Also explore CERENO SCIENTIFIC AB B (4A1) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for CERENO SCIENTIFIC AB B (2021–2025)
Year-by-year debt coverage analysis for CERENO SCIENTIFIC AB B. For market capitalisation and broader financial context, see CERENO SCIENTIFIC AB B (4A1) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.74x | €-111.86 Million | €150.20 Million | ▼ -59.8% |
| 2024 | -0.47x | €-103.42 Million | €221.85 Million | ▲ +13.4% |
| 2023 | -0.54x | €-36.92 Million | €68.56 Million | ▲ +59.1% |
| 2022 | -1.32x | €-18.62 Million | €14.14 Million | ▼ -6.9% |
| 2021 | -1.23x | €-13.14 Million | €10.67 Million | — |